2月25日，荣科科技涨2.20%，成交额3.50亿元。两融数据显示，当日荣科科技获融资买入额3326.96万 元，融资偿还2860.89万元，融资净买入466.06万元。截至2月25日，荣科科技融资融券余额合计9.44亿 元。 融资方面，荣科科技当日融资买入3326.96万元。当前融资余额9.44亿元，占流通市值的8.36%，融资余 额低于近一年40%分位水平，处于较低位。 资料显示，荣科科技股份有限公司位于辽宁省沈阳市沈阳经济技术开发区开发大路7甲3号，成立日期 2005年11月18日，上市日期2012年2月16日，公司主营业务涉及智慧医疗、健康数据和智维云。主营业 务收入构成为：自主产品及服务73.25%，系统集成26.64%，其他(补充)0.12%。 截至9月30日，荣科科技股东户数5.40万，较上期减少10.80%；人均流通股11834股，较上期增加 12.10%。2025年1月-9月，荣科科技实现营业收入4.54亿元，同比减少4.49%；归母净利润-3169.01万 元，同比减少378.82%。 分红方面，荣科科技A股上市后累计派现9914.27万元。近三年，累计派现0.00元。 机构持仓方面，截止 ...

Core Viewpoint - The company has appointed Lixin Certified Public Accountants (Special General Partnership) as the auditing firm for its 2025 fiscal year, with the audit report expected to be released on April 24, 2026 [1] Group 1 - The company will provide updates on the audit report through official announcements [1] - The appointment of the auditing firm is part of the company's compliance and governance practices [1]

Core Viewpoint - The company focuses on the smart healthcare sector, aiming for high-quality development through product iteration, market expansion, cost optimization, and resource integration [2] Group 1: Business Strategy - The company is enhancing its profitability by improving its product offerings in AI medical record quality control, emergency critical care, and closing data loops for perioperative care [2] - The company supports intelligent review of medical insurance DRG/DIP and intelligent triage and guidance as part of its product strategy [2] Group 2: Market Focus - The company plans to strengthen regional market collaboration to improve profitability as a core objective [2] - The company commits to regularly disclosing significant business progress to protect the rights of all shareholders [2]

Group 1 - The company confirmed that there are no undisclosed matters or related plans, discussions, or agreements that need to be disclosed according to the Shenzhen Stock Exchange's listing rules [2] - The statement was made in response to investor inquiries on the company's interactive platform [2] - The announcement regarding abnormal stock trading fluctuations was published on January 9, 2026 [2]

Core Viewpoint - Rongke Technology (300290) is focusing on "AI + healthcare" strategic layout and aims to improve performance by optimizing costs and receivables in 2026 [1] Group 1 - The company is committed to enhancing profitability through capital operations that align with its development strategy, with any plans to be disclosed in compliance with regulations [1] - As of February 11, 2026, the company’s Secretary reiterated that there are currently no significant matters to disclose, including asset restructuring or cross-industry merger plans [1]

Core Viewpoint - Rongke Technology (300290) is optimizing its financial structure and enhancing investor returns by addressing accumulated losses in compliance with the new Company Law and relevant financial regulations [1] Group 1 - The company is focusing on its core business development while implementing loss compensation as a compliant financial optimization strategy [1] - The actions taken are aimed at improving the company's financial health and ensuring long-term returns for investors [1] - The company emphasizes that the loss compensation is a necessary step under the premise of compliance [1]

Group 1 - The core viewpoint of the article is that Rongke Technology (300290.SZ) is actively engaging in business activities through its subsidiary, Zhiwei Cloud, which focuses on market promotion and project implementation of super fusion servers and related products in the Northeast region [1] - Zhiwei Cloud is currently a super fusion platinum dealer, indicating its strategic positioning in the market [1] - The company is expanding its business into medical and government sectors, showcasing its diversification efforts [1]

Core Viewpoint - The company is utilizing 556 million yuan from its reserve fund to cover losses, which aligns with the new Company Law and aims to optimize its financial statements and clear obstacles for future development [1] Group 1 - The use of reserve funds to cover losses is a compliant operation under the new Company Law and relevant financial regulations [1] - This financial optimization strategy is intended to enhance the company's financial health and improve returns for investors [1] - The company remains focused on its core business development while using loss coverage as a means of financial optimization [1] Group 2 - The company expresses gratitude for investor interest and emphasizes its commitment to long-term value creation [1] - There is an implication that the company will provide further details on how it plans to leverage its improved financial structure for profit distribution, refinancing, or core business investments in the future [1]

Core Viewpoint - The collaboration between the company's subsidiary and Super Fusion is perceived as a potential positive development by the market, prompting inquiries about the specifics of the partnership, including scale, profit contribution expectations, duration, and future expansion plans [1] Group 1: Company Collaboration Details - The company confirmed that its subsidiary, Zhihuiyun, is currently a platinum distributor for Super Fusion, focusing on the Northeast region [1] - The collaboration aims to promote Super Fusion servers and related products in medical and governmental scenarios [1] - This type of business cooperation is categorized as a normal commercial activity for the company [1]

Core Viewpoint - The company asserts that its strategies in "AI + healthcare" and "smart cities" represent genuine business initiatives rather than mere marketing gimmicks, despite ongoing losses in its core business [2]. Group 1: Business Strategy - The company emphasizes that its strategic focus on "AI + healthcare" is a legitimate business layout, currently in the market introduction phase, resulting in low revenue contribution [2]. - The company acknowledges that its financial performance is under pressure due to industry adjustments and upfront R&D investments, which are considered temporary factors [2]. Group 2: Future Plans - The company has developed a profit improvement plan aimed at focusing on high-value sectors, optimizing costs, and enhancing cash flow [2]. - The company aims to achieve performance improvement by 2026, intending to support its strategic initiatives with actual financial results [2].